Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Share-based Compensation (2020 - 2026)

Maxcyte has reported Share-based Compensation over the past 6 years, most recently at $706000.0 for Q4 2025.

  • Quarterly Share-based Compensation fell 77.47% to $706000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.2 million through Dec 2025, down 29.58% year-over-year, with the annual reading at $9.2 million for FY2025, 29.58% down from the prior year.
  • Share-based Compensation was $706000.0 for Q4 2025 at Maxcyte, down from $2.0 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $3.6 million in Q3 2023 and troughed at $706000.0 in Q4 2025.
  • The 5-year median for Share-based Compensation is $3.1 million (2022), against an average of $2.8 million.
  • Year-over-year, Share-based Compensation skyrocketed 282.17% in 2021 and then crashed 77.47% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $2.4 million in 2021, then increased by 27.36% to $3.1 million in 2022, then increased by 14.62% to $3.6 million in 2023, then decreased by 12.31% to $3.1 million in 2024, then crashed by 77.47% to $706000.0 in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Share-based Compensation are $706000.0 (Q4 2025), $2.0 million (Q3 2025), and $3.5 million (Q2 2025).